Skip to content
★ Sign in to follow
SM

Susan Moran

Executive
RayzeBio, Inc.BioAtla, Inc.
Total declarations
4
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 18 Jun 2025 for BioAtla, Inc..

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

Susan Moran: trading record in brief

Filings by Susan Moran span 2 companies, the busiest being BioAtla, Inc. and RayzeBio, Inc. Over a trading history stretching from 22 January 2024 to 18 June 2025, the count stands at 4 filings.

Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The latest filing, published on 18 June 2025, reports a share grant in BioAtla, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Susan Moran

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ◆
    DirectorExecutivesBioAtla, Inc.
    0SEC
    23,500 shares0Common StockSEC:0000950170-25-088065:0
  • ◆
    DirectorExecutivesBioAtla, Inc.
    0SEC
    16,500 shares0Common StockSEC:0000950170-24-073659:0
  • ●
    CHIEF MEDICAL OFFICERExecutivesRayzeBio, Inc.
    20M USD19SEC
    323,455 shares@ US$62.5099.5% of flowCommon StockSEC:0001415889-24-005507:0
  • ◇
    CHIEF MEDICAL OFFICERExecutivesRayzeBio, Inc.
    100,035 USD11SEC
    30,875 shares@ US$3.240.5% of flowCommon StockSEC:0001415889-24-002852:0

4 of 4 declarations